Live
Octapharma - Blood Disorder Treatment products (inc Haemophilia A & B)
£71,550
goods
Contract Details
- Tender Value
- £71,550
- Stage
- Live
- Published
- Awarded
Timeline
Awarded
Start
Disclosed
End
Description
Call off contract/order from the NHS National Framework Agreement for the supply of products for the treatment of Blood Disorders including Haemophilia A & B. Offer reference number: CM/PHS/22/5661 Specifically for products: Fibryga Octaplas
Related Contracts
From This Buyer
From This Supplier
- Octapharma Ltd - Octaplas LG
£52,500 ·
- Octaplex Treatment
£100,000 ·
- Blood product required for the treatment of TTP patients
£97,500 ·
- Human Normal Immunoglobulin and Anti-D Immunoglobulin
£450,000,000 ·
In This Category
Ref: 10b5dbb7-eeb1-4711-b3b4-a963723a3283-833189 · Sourced from Contracts Finder
View source notice